pLenti CMV TRE3G Neo GFP-Progerin Citations (3)

Originally described in: A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds.
Kubben N, Brimacombe KR, Donegan M, Li Z, Misteli T Methods. 2015 Sep 1. pii: S1046-2023(15)30070-0. doi: 10.1016/j.ymeth.2015.08.024. PubMed Journal

---

Articles Citing pLenti CMV TRE3G Neo GFP-Progerin

Articles
Progerin induces a phenotypic switch in vascular smooth muscle cells and triggers replication stress and an aging-associated secretory signature. Coll-Bonfill N, Mahajan U, Shashkova EV, Lin CJ, Mecham RP, Gonzalo S. Geroscience. 2023 Apr;45(2):965-982. doi: 10.1007/s11357-022-00694-1. Epub 2022 Dec 9. PubMed
Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues. Rolas L, Stein M, Barkaway A, Reglero-Real N, Sciacca E, Yaseen M, Wang H, Vazquez-Martinez L, Golding M, Blacksell IA, Giblin MJ, Jaworska E, Bishop CL, Voisin MB, Gaston-Massuet C, Fossati-Jimack L, Pitzalis C, Cooper D, Nightingale TD, Lopez-Otin C, Lewis MJ, Nourshargh S. EMBO Rep. 2024 Sep;25(9):3842-3869. doi: 10.1038/s44319-024-00182-x. Epub 2024 Jun 25. PubMed
Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in Antitumoral Immunity. Jeong DH, Kim S, Park HH, Woo KJ, Choi JI, Choi M, Shin J, Park SH, Seon MW, Lee D, Cha JH, Kim YS. Adv Sci (Weinh). 2025 Apr;12(13):e2412393. doi: 10.1002/advs.202412393. Epub 2025 Feb 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.